Dr. Douglas Allan Receives co-funded grant from Alzheimer Society and Brain Canada
June 20, 2025
LSI researcher Dr. Douglas Allan has been awarded a Proof of Concept Grant through the Alzheimer Society Research Program, co-funded by Brain Canada Foundation.
This national initiative is investing $5.1 million in 37 promising dementia research projects in 2025. Dr. Allan’s project, “A universal platform for high volume genetic modifier testing in Tauopathy,” aims to accelerate the identification of harmful Tau gene mutations associated with dementia.
By developing a fruit fly system that uses high speed genetics, his team will sort benign from toxic human Tau mutations. This approach will not only help clinicians interpret genetic test results but also reveal critical regions of the Tau protein involved in neurodegeneration—laying the groundwork for more targeted and effective therapies.
Latest News
Fluids, rest, and a broad-spectrum antiviral
February 7, 2026
LSI researchers awarded funding in Fall 2025 CIHR Project Grant competition
January 30, 2026
Glowing bacterial sensors detect gut illness in mice before symptoms emerge
January 28, 2026
Scientists develop first gene-editing treatment for skin conditions
January 27, 2026
Competition now open for the 2026 CBR/LSI Summer Studentship Program
January 19, 2026
Research paves the way for safer colonoscopy bowel prep for people with compromised gut health
January 9, 2026
UBC scientists discover “distress signal” cells use when their power supply is failing
December 18, 2025
UBC researchers uncover how statins harm muscles—and how to stop it
November 26, 2025
UBC enzyme technology clears first human test toward universal donor organs for transplantation
October 8, 2025
UBC launches world’s first mushroom-powered, waterless toilet with help from Hallam Lab
October 2, 2025
Dr. Kayla King awarded Royal Society’s Francis Crick Medal
September 16, 2025
Dr. Emilia Lim investigates wildfire smoke’s health toll with Genome BC funding
September 9, 2025
Dr. Steven Hallam named 2025 UBC Wall Research Award recipient
September 8, 2025
Dr. Yossef Av-Gay’s team reveals 70-year-old Parkinson’s drug’s promise against Tuberculosis
August 29, 2025
Building an inclusive TA training program in the life sciences
August 25, 2025